Aerosolized clindamycin is superior to aerosolized dexamethasone or clindamycin-dexamethasone combination in the treatment of severePorphyromonas gingivalisaspiration pneumonia in an experimental murine model
Authors:
- 28 November 2011
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 38 (1) , 9-18
Abstract
Adjunctive corticosteroid treatment to reduce excessive local inflammatory response in pneumonia is controversial. To study the effects of an early local adjunct dexamethasone treatment on the course of pneumonia and inflammatory/cytokine response, mice were intratracheally inoculated with live Porphyromonas gingivalis and treated with either clindamycin (C), dexamethasone (D), C+D combination, or were not treated (Pg). Six mice from each group were euthanized at 6, 24, 72, and 168 hours after inoculation. Levels of tumor necrosis factor (TNF)-α, soluble TNF-α receptors (sTNFR1 and sTNFR2), interleukin (IL)-1β, and IL-6 in the serum and lung-homogenate supernatant were determined. Lung samples were histopathologically assessed and all findings compared to those found in 24 sham-inoculated mice (phosphate-buffered saline [PBS]). Severe P. gingivalis–induced bronchopneumonia progressed from 24 hours, peaked at 72 hours, and resolved after 168 hours with changes in local and systemic cytokine levels. Clindamycin-treated mice developed only mild bronchopneumonia that resolved fast (72 hours) with an early (6–24 hours) normalization of local and systemic cytokine levels. Similar course of pneumonia and cytokine level changes were observed in mice treated with C+D, but later. Early (6–24 hours) local elevation of sTNFRs was observed in C and C+D groups of mice, whereas nontreated (Pg) mice had increased systemic sTNFRs. Severe bronchopneumonia with delayed resolution was observed in D-group mice, with an early local and systemic decrease in sTNFR1 and persistent elevation of local TNF-α. Clindamycin or a clindamycin-dexamethasone combination treatment significantly improves the course of P. gingivalis-aspiration pneumonia, but more so if clindamycin alone is used. A favorable course of pneumonia seems to be associated with an early elevation of sTNFRs and normalization of TNF-α.Keywords
This publication has 38 references indexed in Scilit:
- The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung InjuryThe Journal of Immunology, 2009
- Adjunctive Therapy in Community-Acquired PneumoniaSeminars in Respiratory and Critical Care Medicine, 2009
- The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationBlood, 2008
- The Impact of Steroids Given with Macrolide Therapy on ExperimentalMycoplasma pneumoniaeRespiratory InfectionThe Journal of Infectious Diseases, 2008
- Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Effects of glucocorticoids in ventilated piglets with severe pneumoniaEuropean Respiratory Journal, 2008
- Antimicrobial susceptibility of periodontopathogenic bacteriaJournal of Antimicrobial Chemotherapy, 2008
- Acute Lower Respiratory Tract InfectionNew England Journal of Medicine, 2008
- Effects of etanercept, a tumour necrosis factor‐α antagonist, in an experimental model of periodontitis in ratsBritish Journal of Pharmacology, 2007
- Aspiration pneumoniaPostgraduate Medicine, 2003